2014 0424 ASM Vote


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K
  
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported):  April 24, 2014


(Exact name of registrant as specified in its charter)
 

New Jersey
I-3215
22-1024240
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 

One Johnson & Johnson Plaza, New Brunswick, New Jersey  08933
(Address of Principal Executive Offices) (Zip Code)
  
Registrant's telephone number, including area code:  732-524-0400
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))










Item 5.07 Submission of Matters to a Vote of Security Holders.
 
(a)           The annual meeting of the shareholders of the company was held on April 24, 2014.
 
(b)           At the meeting, the shareholders:

•
elected all 12 Director nominees named in the 2014 Proxy Statement to the company's Board of Directors;
•
approved, on an advisory basis, the executive compensation philosophy, policies and procedures described in the Compensation Discussion and Analysis section of the 2014 Proxy Statement and the compensation of the company's executive officers named in the 2014 Proxy Statement, as disclosed therein;
•
ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm for the fiscal year 2014.
   
The shareholders did not approve the following shareholder proposal: Executives to Retain Significant Stock.
 
The following are the final voting results for each of the four items voted on at the meeting.

1.    Election of Directors:

 
 
Shares For
 
Shares Against
 
Shares Abstain
 
Non-Votes
M. S. Coleman
 
1,873,270,310

 
 
18,258,239

 
 
5,377,596

 
 
452,079,715

 
J. G. Cullen
 
1,840,416,009

 
 
50,866,626

 
 
5,623,510

 
 
452,079,715

 
I. E. L. Davis
 
1,878,730,879

 
 
12,546,512

 
 
5,628,754

 
 
452,079,715

 
A. Gorsky
 
1,830,914,634

 
 
53,148,133

 
 
12,843,378

 
 
452,079,715

 
S. L. Lindquist
 
1,882,046,933

 
 
9,626,765

 
 
5,232,447

 
 
452,079,715

 
M. B. McClellan
 
1,883,473,638

 
 
7,807,181

 
 
5,625,326

 
 
452,079,715

 
A. M. Mulcahy
 
1,702,995,790

 
 
188,773,766

 
 
5,136,589

 
 
452,079,715

 
L. F. Mullin
 
1,849,429,962

 
 
41,761,040

 
 
5,715,143

 
 
452,079,715

 
W. D. Perez
 
1,870,833,397

 
 
20,328,655

 
 
5,744,093

 
 
452,079,715

 
C. Prince
 
1,697,440,419

 
 
193,665,378

 
 
5,800,348

 
 
452,079,715

 
A. E. Washington
 
1,877,354,975

 
 
13,699,205

 
 
5,851,965

 
 
452,079,715

 
R. A. Williams
 
1,856,021,582

 
 
35,336,688

 
 
5,547,875

 
 
452,079,715

 

2.    Advisory Vote to Approve Name Executive Officer Compensation:

For
1,810,559,443

 
Against
69,434,352

 
Abstain
16,912,350

 
Non-Votes
452,079,715

 

3.    Ratification of Appointment of Independent Registered Public Accounting Firm
(PricewaterhouseCoopers LLP)

For
2,313,360,023

 
Against
27,240,909

 
Abstain
8,384,928

 





4.    Shareholder Proposal on Executives to Retain Significant Stock

For
494,586,494

 
Against
1,386,921,615

 
Abstain
15,398,036

 
Non-Votes
452,079,715

 




Item 8.01  Other Events.

On April 24, 2014, the Board of Directors of the company declared a regular quarterly dividend of $0.70 per share on the Common Stock of the Company, par value $1.00 per share, payable on June 10, 2014 to shareholders of record as of the close of business on May 27, 2014.  The company's related press release is attached to this Report as Exhibit 99.1.

Item 9.01  Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit No.      Description

99.1        Johnson & Johnson Press Release dated April 24, 2014.





SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
  

 
 
Johnson & Johnson
 
 
 
 (Registrant)
 
 
 
 
Date:  April 25, 2014
By:
/s/ Douglas K. Chia
 
 
 
Douglas K. Chia
 
 
 
Secretary